Pacific Biosciences of California

Pacific Biosciences of California ( PACB), which is engaged in design, development and commercialization of innovative tools for biological research, is trading up 8.1% to $2.39 in recent trading.

Today's Range: $2.20-$2.40

52-Week Range: $1.06-$3.99

Volume: 327,000

Three-Month Average Volume: 514,302

From a technical perspective, PACB is soaring higher here right above some near-term support at $2.16 to $2.13 with solid upside volume. This move is quickly pushing shares of PACB within range of triggering a near-term breakout trade. That trade will hit if PACB manages to take out its 50-day at $2.39 and then once it clears more overhead resistance levels at $2.64 to $2.73 with high volume.

Traders should now look for long-biased trades in PACB as long as it's trending above $2.16, and then once it sustains a move or close above those breakout levels with volume that hits near or above 514,302 shares. If that breakout triggers soon, then PACB will set up to re-test or possibly take out its next major overhead resistance levels at $3.25 to $3.99.

LCA-Vision

LCA-Vision ( LCAV) is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. This stock is trading up 6.3% to $3.35 in recent trading.

Today's Range: $3.15-$3.36

52-Week Range: $2.67-$7.50

Volume: 86,000

Three-Month Average Volume: 102,995

From a technical perspective, LCAV is ripping higher here back above its 50-day moving average of $3.14 with decent upside volume. This stock recently formed a double bottom at around $2.78 to $2.83 and it has now broken out above some near-term overhead resistance levels at $3.08 to its 50-day at $3.14. Shares of LCAV are now quickly moving within range of triggering another major breakout trade. That trade will hit if LCAV manages to take out some near-term overhead resistance levels at $3.50 to $3.60 and then once it clears its 200-day at $3.68 with high volume.

Traders should now look for long-biased trades in LCAV as long as it's trending above its 50-day at $3.14, and then once it sustains a move or close above those breakout levels with volume that hits near or above 102,995 shares. If that breakout triggers soon, then LCAV will set up to re-test or possibly take out its next major overhead resistance levels at $4.10 to $4.32. Any high-volume move above those levels will then put $4.60 into range for shares of LCAV.

If you liked this article you might like

5 Stocks Insiders Love Right Now

Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection

5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy

Insider Trading Alert - SMLP, DRRX And MDSO Traded By Insiders

Insider Trading Alert - DRRX, EA and KAI Traded By Insiders